Concepedia
Statistics
Publications
9
Citations
319
H-Index
Active since
2008
Affiliations
University of Cincinnati Medical Center(Current)
University of North Carolina at Chapel Hill
Medical University of South Carolina
Cincinnati Children's Hospital Medical Center
University of Cincinnati
Clayton S. Lewis is an author at University of Cincinnati Medical Center specializing in medicine, molecular oncology, and oncology.
Publications per year
2008–2022
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts
Vladimir Beljanski, Clayton S. Lewis, Charles D. Smith · Cancer Biology & Therapy · 2011 · 103 citations · Full text
Medicine, Oncology, Pharmacology +17
LCL124, a Cationic Analog of Ceramide, Selectively Induces Pancreatic Cancer Cell Death by Accumulating in Mitochondria
Thomas H. Beckham, Ping Lü, E. Ellen Jones et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 52 citations · Full text
Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640
Clayton S. Lewis, Christina Voelkel‐Johnson, Charles D. Smith · Oncotarget · 2016 · 42 citations · Full text
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma
Dusten Unruh, Betül Ünlü, Clayton S. Lewis et al. · Oncotarget · 2016 · 33 citations · Full text
Medicine, Cancer Biology, Oncology +11
Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer
Kombo F. N’Guessan, Harold W. Davis, Zhengtao Chu et al. · Molecular Therapy · 2020 · 23 citations · Full text
1–5 of 9